Olema Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -94 | -88 | ||
EBITDA | -36,652 | -37,526 | -33,436 | -34,251 |
EBIT | -36,768 | -37,621 | -33,530 | -34,339 |
Net Income | -33,567 | -34,555 | -30,382 | -30,970 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -26,284 | -26,857 | -27,561 | -23,649 |
Cash | 139,480 | 35,888 | 16,892 | 33,720 |
Basic Shares | 58,743 | 57,262 | 56,282 | 55,574 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -377 | -1,658 | -1,663 | |
EBITDA | -142,258 | -104,584 | -106,631 | -69,433 |
EBIT | -104,961 | -106,988 | -71,096 | |
Net Income | -129,474 | -96,655 | -102,586 | -70,886 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 9,890 | -324,737 | ||
Free Cash Flow | -104,351 | -83,727 | -82,428 | -52,265 |
Cash | 139,480 | 68,539 | 23,702 | 287,250 |
Basic Shares | 58,743 | 45,247 | 39,995 | 39,524 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.51 |
2024-09-30 | -$0.60 |
2024-06-30 | -$0.54 |
2024-03-31 | -$0.56 |
